missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IFN-alpha H2/IFNA14 Protein
Click to view available options
Quantity:
10 μg
50 μg
Unit Size:
10µg
50µg
Description
Measured in anti-viral assays using HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129. The ED50 for this effect is 1.50-15.0 pg/mL.
Specifications
Specifications
| Accession Number | P01570.3 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Gene ID (Entrez) | 3448 |
| Molecular Weight (g/mol) | M.W.-observed: 22-26 kDa, under reducing conditions., M.W.-theroretical: 20 kDa |
| Quantity | 10 μg |
| Source | Human embryonic kidney cell, HEK293-derived IFN-alpha H2/IFNA14 protein Cys24-Asp189 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Gene Alias | IFNA14, IFNalpha H2, IFN-alpha-14, IFN-alphaH, interferon alpha-14, Interferon alpha-H, Interferon lambda-2-H, interferon, alpha 14, LeIF H, LEIF2H, MGC125756, MGC125757 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction